Maxivision Eye Hospitals is launching an aggressive expansion in Gujarat with a ₹150 crore investment planned over the next two years. The goal is to more than double its network in the state, growing from 10 to 20 facilities. This significant funding reflects a focus on high-growth regional markets and includes plans to explore new locations such as Vapi and Vadodara.
Scaling Up in Gujarat
The company currently operates four hospitals in Rajkot, two each in Surat and Ahmedabad, and one each in Morbi and Jamnagar. This existing base is being expanded through a mix of new construction and strategic partnerships. The Gujarat market shows strong demand for specialized eye care, driven by population growth and economic development, a trend seen across India's eye care sector.
Strategic Partnerships Boost Growth
A key part of the expansion is a new collaboration with SRG Eye Hospital in Ahmedabad. This partnership aims to significantly boost Maxivision's presence in the city, with plans for five new centers. Maxivision has a history of using a doctor-partnership model, with about 20 such arrangements across India, to integrate local medical expertise and scale services effectively in different regions.
Industry Context
As a private company, Maxivision's expansion can be viewed against publicly traded hospital chains. For example, Krishna Institute of Medical Sciences Ltd. (KIMS Hospitals), a listed Indian healthcare provider, has a market value between ₹30,000-₹35,000 crore and a typical price-to-earnings ratio of 40-50 times earnings. This reflects investor confidence in India's healthcare growth. Expanding hospitals is capital-intensive, requiring sustained investment and strategic planning for long-term success.
Operational Focus
Maxivision's growth plan includes investing in advanced medical technology and efficient operations. This technology focus is vital in eye care, where modern equipment can improve patient outcomes and service quality. The challenge will be integrating new technologies across the expanding network while maintaining consistent service standards and operational synergy.
Potential Risks and Challenges
While ambitious, Maxivision's expansion faces risks. Its reliance on the doctor-partnership model could create challenges in maintaining consistent governance and control across more affiliated locations. Integrating SRG Eye Hospital and other future partners requires careful execution to ensure smooth operations and achieve synergy. The eye care market is also growing more competitive, with national chains and large hospital groups expanding. Maxivision's plan to enter new states like Karnataka, Goa, Madhya Pradesh, and Odisha this year, alongside its Gujarat push, increases execution risk and strains capital. Dr. G.S.K. Velu's involvement in multiple healthcare ventures means careful resource allocation is needed to prevent management from becoming too spread thin. Long-term profitability will depend on attracting patients, managing costs, and setting competitive prices.
Future Outlook
The company aims to strengthen its position in Gujarat and expand into new Indian regions within the current fiscal year. This national growth strategy positions Maxivision to capitalize on consolidation and expansion in India's healthcare sector. Gujarat's expansion success could serve as a model for further growth in other promising regional markets, improving access to quality healthcare in smaller cities.
